| Christine Anne Royer, MD | |
|
130 Stony Point Rd Ste E, Santa Rosa, CA 95401-4120 | |
| (707) 525-0211 | |
| Not Available |
| Full Name | Christine Anne Royer |
|---|---|
| Gender | Female |
| Speciality | Allergy & Immunology |
| Location | 130 Stony Point Rd Ste E, Santa Rosa, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730566613 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | A169502 (California) | Primary |
| Entity Name | Allergy & Asthma Adult & Pediatric Medical Group Of The Redwoods Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730257932 PECOS PAC ID: 8921084773 Enrollment ID: O20110209000107 |
News Archive
Oncothyreon Inc. announced today that Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax and, through its affiliate EMD Serono Canada Inc., purchased current inventory and certain assets utilized for the manufacture of Stimuvax from Oncothyreon for consideration which includes net payments to Oncothyreon totaling approximately U.S. $13 million.
Reforms introduced as a result of the Sally Clark case could lead to a halving in the number of cases of unexplained infant deaths and a positive legacy emerging from tragedy, says a feature in this week's BMJ.
University of Utah researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) delays or prevents hypertrophic cardiomyopathy, a type of a heart failure in which the heart muscle grows abnormally thick.
During embryo development, genes are dynamically, and very precisely, switched on and off to confer different properties to different cells and build a well-proportioned and healthy animal. Fgf8 is one of the key genes in this process, controlling in particular the growth of the limbs and the formation of the different regions of the brain. Researchers at EMBL have elucidated how Fgf8 in mammal embryos is, itself, controlled by a series of multiple, interdependent regulatory elements.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
› Verified 2 days ago
| Entity Name | Baychildrens |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043628316 PECOS PAC ID: 9638403819 Enrollment ID: O20190621000031 |
News Archive
Oncothyreon Inc. announced today that Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax and, through its affiliate EMD Serono Canada Inc., purchased current inventory and certain assets utilized for the manufacture of Stimuvax from Oncothyreon for consideration which includes net payments to Oncothyreon totaling approximately U.S. $13 million.
Reforms introduced as a result of the Sally Clark case could lead to a halving in the number of cases of unexplained infant deaths and a positive legacy emerging from tragedy, says a feature in this week's BMJ.
University of Utah researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) delays or prevents hypertrophic cardiomyopathy, a type of a heart failure in which the heart muscle grows abnormally thick.
During embryo development, genes are dynamically, and very precisely, switched on and off to confer different properties to different cells and build a well-proportioned and healthy animal. Fgf8 is one of the key genes in this process, controlling in particular the growth of the limbs and the formation of the different regions of the brain. Researchers at EMBL have elucidated how Fgf8 in mammal embryos is, itself, controlled by a series of multiple, interdependent regulatory elements.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Anne Royer, MD 135 Waterside Cir, San Rafael, CA 94903-2777 Ph: (207) 233-2255 | Christine Anne Royer, MD 130 Stony Point Rd Ste E, Santa Rosa, CA 95401-4120 Ph: (707) 525-0211 |
News Archive
Oncothyreon Inc. announced today that Merck KGaA of Darmstadt, Germany has licensed the right to manufacture Stimuvax and, through its affiliate EMD Serono Canada Inc., purchased current inventory and certain assets utilized for the manufacture of Stimuvax from Oncothyreon for consideration which includes net payments to Oncothyreon totaling approximately U.S. $13 million.
Reforms introduced as a result of the Sally Clark case could lead to a halving in the number of cases of unexplained infant deaths and a positive legacy emerging from tragedy, says a feature in this week's BMJ.
University of Utah researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) delays or prevents hypertrophic cardiomyopathy, a type of a heart failure in which the heart muscle grows abnormally thick.
During embryo development, genes are dynamically, and very precisely, switched on and off to confer different properties to different cells and build a well-proportioned and healthy animal. Fgf8 is one of the key genes in this process, controlling in particular the growth of the limbs and the formation of the different regions of the brain. Researchers at EMBL have elucidated how Fgf8 in mammal embryos is, itself, controlled by a series of multiple, interdependent regulatory elements.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has established a platform business in the ophthalmology market. The new platform company, Beaver-Visitec International, Inc., consists of ophthalmology products and assets recently acquired from BD and Medtronic, Inc.
› Verified 2 days ago
Mr. Michael E Martin, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2461 Summerfield Rd, Santa Rosa, CA 95405 Phone: 707-525-0211 Fax: 707-525-0491 | |
Dr. Maria M. Petrick, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 130 Stony Point Rd, Suite E, Santa Rosa, CA 95401 Phone: 707-525-0211 Fax: 707-525-0491 | |
Dr. Kenneth M. Kurtz, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 | |
Albert Haas Iii, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 401 Bicentennial Way, Santa Rosa, CA 95403 Phone: 707-571-4000 | |
Juline Natalia Caraballo Fonseca, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 130 Stony Point Rd Ste E, Santa Rosa, CA 95401 Phone: 707-525-0211 Fax: 707-525-0491 |